All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...773Next →

hiv & aids news selected from other sources

  • Money, benefits and housing
    Association of British Insurers guide on life insurance to support customers with HIV
    Association of British Insurers | 3 hours ago

    A new guide has been produced by the Association of British Insurers to inform customers with HIV about life insurance.It lets people living with HIV know that they can get life insurance, and that they do not need to cancel an existing policy if they become HIV positive.

  • Hepatitis C treatment
    Hepatitis C will be eradicated from Australia in a decade, doctors say
    Sydney Morning Herald | 4 hours ago

    Doctors are predicting the eradication of hepatitis C from Australia by 2026 after a dramatic take-up of new-generation "revolutionary" drugs. Nearly 22,500 patients have commenced treatment since the drugs were listed on the Pharmaceutical Benefits Scheme in March, representing about 10 per cent of all people who are estimated to be living with hepatitis C.

  • Hepatitis C treatment
    NHS England tried to sabotage hepatitis C drugs release because it couldn't afford them, doctors claim
    The Independent | 4 hours ago

    NHS England tried to sabotage the release of hepatitis C drugs because it couldn't afford them, it has been claimed. Under current procedures, drugs approved by Nice typically become widely available to NHS patients after a statutory period of 90 days. However, the BMJ claims: “In an apparent panic over high prices and affordability, NHS England deployed many delaying tactics to block timely access to the hepatitis C drugs.”

  • Sexual transmission
    How Three New studies Unravel South Africa's Patterns of HIV Transmission
    The Good Men Project (blog) | 21 hours ago

    Three studies conducted by the Centre for the AIDS Programme of Research in South Africa (Caprisa) in rural and urban sub-districts of the KwaZulu-Natal province provide new insights into the engine that drives HIV transmission in the country. They also reveal a new way to tackle the problem of HIV. Caprisa’s director Professor Salim Abdool-Karim explains the latest findings.

  • Hepatitis B
    'Screen-and-treat' scheme for hepatitis B may prevent deadly complications
    Eurekalert Inf Dis | 21 hours ago

    Research into Africa's first 'screen-and-treat' programme for hepatitis B suggests the initiative may reduce deadly complications of the virus. The new findings, from researchers at a number of international institutions including Imperial College London and the Medical Research Council Unit The Gambia, also suggest the initiative is feasible and cost-effective.

  • HIV prevention policy
    As EU Approval Moves Closer Are Governments Prepared For PrEP?
    Seeking Alpha | 27 July 2016

    On Friday the EU's Committee for Medicinal Products for Human Use (CHMP) announced its positive opinion on Gilead’s HIV pre-exposure prophylaxis product Truvada PrEP. But with many European governments trying to control healthcare costs, the biggest issue facing Truvada PrEP might not be approval but rather reimbursement.

  • Prince Harry's HIV test inspired a 500% increase in people checking their status, says charity
    Daily Mirror | 27 July 2016

    The Terrence Higgins Trust described the effect of the prince’s social media appeal as a “groundbreaking moment in the fight against HIV ”. The charity was running a pilot scheme offering people the chance to find out their status by sending off for a 15-minute HIV self-testing kit when Harry sat down for his test on Thursday July 14.

  • Prisoners
    Prisoners pose biggest risk for HIV infection rates in the EECA
    University of Bristol | 26 July 2016

    Prisoners are likely to be the primary risk group for HIV infections in Eastern Europe in the next 15 years, researchers from the University of Bristol have found. Their study was published as part of series in the Lancet on HIV and related infections in prisoners, which was also presented at this month's International AIDS Conference in Durban, South Africa.

  • Hepatitis C treatment
    CHMP Grants Positive Opinion for Shorter Treatment Duration with AbbVie's VIEKIRAX® for Patients with Genotype 4 Chronic Hepatitis C with Compensated Cirrhosis (Child-Pugh A)
    AbbVie press release | 26 July 2016

    AbbVie announced today that the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has granted a positive opinion for the use of 12 weeks of VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) with ribavirin (RBV) in genotype 4 (GT4) chronic hepatitis C virus (HCV) infected adult patients with compensated cirrhosis (Child-Pugh A). VIEKIRAX with RBV is currently approved in the European Union for GT4 patients with compensated cirrhosis for 24 weeks.

  • Nutrition
    Vitamin D supplements 'advised for everyone'
    BBC Health | 25 July 2016

    Everyone should consider taking vitamin D supplements in autumn and winter, public health advice in England and Wales says.

← First12345...1217Next →

Conference news

News from the ASM Microbe conference in Boston.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap